Filter by patients with: All

What is Octreotide?

Category: Prescription Drugs

Most popular types: Sandostatin Sandostatin LAR Depot

false

Octreotide is used to control diarrhea and flushing in patients with metastatic carcinoid tumors; for the treatment of watery diarrhea associated with vasoactive intestinal peptide-secreting tumors (VIPomas); and for treatment of acromegaly.

See patients taking Octreotide

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Carcinoid syndrome 16 10
Neuroendocrine tumor 6 3
Acromegaly syndrome 5 4
Pancreatic neuroendocrine tumor 5 1
Gastrointestinal neuroendocrine tumor 3 3
Benign brain tumor 1 0

Show all 10 reasons taken

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 40 patients that have taken Octreotide

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 2
Moderate 6
Mild 4
None 7

Commonly reported side effects and conditions associated with Octreotide

Side effect Patients Percentage
Fatigue 3
Nausea 2
Cramps in legs 1
Diarrhea 1
Flatulence 1
Gas pain 1

Show all 11 reported side effects

Dosages

Based on patients currently taking Octreotide

Dosage Patients Percentage
20 mg monthly 1

Why patients stopped taking Octreotide

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 4
Did not seem to work 2
Course of treatment ended 1
Side effects too severe 1
See all 7 patients who've stopped taking Octreotide

Duration

Currently taking Octreotide

Duration Patients Percentage
10 years or more 1

Stopped taking Octreotide

Duration Patients Percentage
Less than 1 month 1
1 - 6 months 2
6 months - 1 year 2
1 - 2 years 2
2 - 5 years 1
Adherence
Adherence Evaluations Percentage
Always 18
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 5
A little hard to take 4
Not at all hard to take 10
Cost per month
Cost per month Evaluations Percentage
$200+ 4
$100-199 2
$50-99 0
$25-49 1
< $25 7
Not specified 5

What people switch to and from

Patients started taking Octreotide after stopping:

Treatment Patients Percentage
Cabergoline (Dostinex) 1
Cyproheptadine (Periactin) 1
Octreotide (Sandostatin) 1
Temozolomide (Temodar) 1

Patients stopped taking Octreotide and switched to:

Treatment Patients Percentage
Lanreotide (Somatuline Depot) 2
Everolimus (Afinitor) 1
Octreotide (Sandostatin) 1
Last updated:
There are no evaluations for Octreotide.